ABACUS MEDICINE A/S — Credit Rating and Financial Key Figures

ABACUS MEDICINE A/S (CVR number: 28111576) is a company from KØBENHAVN. The company reported a net sales of 832.2 mEUR in 2023, demonstrating a growth of 23.2 % compared to the previous year. The operating profit percentage was at 3.3 % (EBIT: 27.9 mEUR), while net earnings were 20 mEUR. The profitability of the company measured by Return on Assets (ROA) was 15.3 %, which can be considered excellent and Return on Equity (ROE) was 28.3 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 28.3 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. ABACUS MEDICINE A/S's liquidity measured by quick ratio was 0.3 which is at a very low level. Thus, the company is in an unstable financial position, with its liquid assets significantly undermatching its current liabilities. This severe liquidity deficiency may lead to financial distress and threaten the company's operational continuity.